(2022). Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitors. Cancer Epidemiol, 78, 102149. http://doi.org/10.1016/j.canep.2022.102149.
F. de Vries
(2001). Use of statins and risk of fractures. Jama..
(2005). Severity of obstructive airway disease and risk of osteoporotic fracture. Eur Respir J. http://doi.org/10.1183/09031936.05.00058204.
(2006). Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database. Int J Epidemiol. http://doi.org/10.1093/ije/dyl147.
(2007). Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands. Calcif Tissue Int. http://doi.org/10.1007/s00223-006-0213-1.
(2007). Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum. http://doi.org/10.1002/art.22294.
(2007). Lithium use and the risk of fractures. Bone. http://doi.org/10.1016/j.bone.2006.12.055.
(2009). Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates. Osteoporos Int. http://doi.org/10.1007/s00198-009-0891-4.
(2009). The pattern of risk of myocardial infarction in patients taking asthma medication: a study with the General Practice Research Database. J Hypertens. http://doi.org/10.1097/HJH.0b013e32832af68d.
(2010). Long-acting beta2-agonists in adult asthma and the pattern of risk of death and severe asthma outcomes: a study using the GPRD. Eur Respir J. http://doi.org/10.1183/09031936.00124209.